Key Elements on the Pathway to HCV Elimination: Lessons Learned From the AASLD HCV Special Interest Group 2020.
Key Elements on the Pathway to HCV Elimination: Lessons Learned From the AASLD HCV Special Interest Group 2020.
复制标题
DOI:
10.1002/hep4.1731
复制
发表时间:
2021-06
影响因子:
5.1
通讯作者:
Ward JW
中科院分区:
文献类型:
--
作者:
Feld JJ;Ward JW
With a decade left to reach the ambitious goals for viral hepatitis elimination set out by the World Health Organization, many challenges remain. Despite the remarkable improvements in therapy for hepatitis C virus (HCV) infection, most people living with the infection remain undiagnosed, and only a fraction have received curative therapy. Accordingly, the 2020 HCV Special Interest Group symposium at the annual American Association for the Study of Liver Diseases Liver Meeting examined policies and strategies for the scale‐up of HCV testing and expanded access to HCV care and treatment outside the specialty setting, including primary care and drug treatment and settings for care of persons who inject drugs and other marginalized populations at risk for HCV infection. The importance of these paradigms in elimination efforts, including micro‐elimination strategies, was explored, and the session also included discussion of hepatitis C vaccine development and other strategies to reduce mortality through the use of organs from HCV‐infected organ donors for HCV‐negative recipients. In this review, the key concepts raised at this important symposium are summarized.
登录
查看更多内容
影响因子:
39.2
作者:
Durand, Christine M.;Bowring, Mary G.;Segev, Dorry L.
通讯作者:
Segev, Dorry L.
影响因子:
5.7
作者:
Faherty, Laura J.;Rose, Adam J.;Fischer, Shira H.
通讯作者:
Fischer, Shira H.
影响因子:
33.9
作者:
Dunn, Rick;Musabaev, Erkin;Nasrullah, Muazzam
通讯作者:
Nasrullah, Muazzam
影响因子:
76.2
作者:
Cypel, Marcelo;Feld, Jordan J.;Humar, Atul
通讯作者:
Humar, Atul
影响因子:
39.2
作者:
Durand CM;Bowring MG;Brown DM;Chattergoon MA;Massaccesi G;Bair N;Wesson R;Reyad A;Naqvi FF;Ostrander D;Sugarman J;Segev DL;Sulkowski M;Desai NM
通讯作者:
Desai NM